Why Most MedTech Founders Blow LATAM Entry | Franklin J. Perez on SDDT LIVE

So Thursday morning I've got Franklin J. Perez on Seriously Don't Do That LIVE and this one's different from anything we've run on the podcast so far. Here's the thing. Every week I get founders asking me about the U.S. market. That's what I do, that's our home turf. But every couple of weeks, someone asks me the other direction - a U.S. or European MedTech founder saying, "Dan, what about Latin America? Should we be looking down there?" And the honest answer has always been: I don't know your ground truth on that market well enough to advise you. So I went and found the guy who does. Franklin's spent 25+ years running commercial infrastructure across LATAM at Medtronic, Edwards Lifesciences, and Abbott. Native Puerto Rican. Decade in Colombia. Now runs LATAM MedTech Growth Partners. If there's a founder in the U.S. or Europe who's ever going to think about LATAM expansion, this is the conversation. Three things we get into: → Why treating Latin America as one market kills the deal before it starts → Franklin's Three Parallel Channels framework - distributor, physician, payer, running simultaneously (not sequentially, which is the mistake most founders make) → Puerto Rico as the LATAM launch pad - FDA-regulated, commercially Latin American, small enough to make your mistakes cheaply And look, I'll be honest with you - Europeans and Asians already have a head start in LATAM. U.S. MedTech companies are leaving money on the table. Franklin lays out exactly why. If you're eyeing LATAM in the next 12 months - even if it's a year or two out - you want to hear this before you sign anything. 🔔 Thursday 9 AM EDT. Register now → Click attend to register for the event. See you Thursday.